ANDA 209595, held by Cosette Pharms Nc. Desoximetasone.
As of Nov 15, 2026, ANDA 209595 (Desoximetasone), held by Cosette Pharms Nc, was first approved by FDA on Mar 4, 2020, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 4, 2020 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Desoximetasone0.25% ยท cream;topical | Desoximetasone | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
